Skip to main content

Find Clinical Trials

Home
Conditions
Hemorrhagic Disorders

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

4,583 public trials 830 recruiting studies

Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Completed

Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia

NCT00004107

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +37 more
Locations: Garden State Cancer Center Belleville, New Jersey, United States

St. Barnabas Medical Center Livingston, New Jersey, United States

St. Joseph's Hospital and Medical Center Paterson, New Jersey, United States

University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

A Study Assessing Safety and Effectiveness of BORTEZOMIB Combination Therapy (Bortezomib + Doxorubicin Hydrochloride + Dexamethasone) in Previously Untreated Multiple Myeloma Patients

NCT00561743

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Study to Determine the Accuracy of Prothrombin Time of Warfarinised Blood

NCT01375725

Conditions: Cardiovascular Diseases, Clotting Disorders, Hematologic Diseases, +4 more
Locations: White River Diagnostic Clinic Batesville, Arkansas, United States

View Trial Details

Completed

Vincristine, DOXIL (Doxorubicin HCl Liposome Injection) and Dexamethasone vs. Vincristine, Doxorubicin, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma

NCT00344422

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +15 more
Locations: Not specified

View Trial Details

Completed

Safety Study of a Chemokine Receptor (CXCR4) Antagonist in Multiple Myeloma Patients

NCT01010880

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Department of Hematology and Bone Marrow Transplantation,Rambam Medical Center Haifa, Israel

Chaim Sheba Medical Center,Tel-Hashomer Ramat Gan, Israel

View Trial Details

Completed

Two Cycles of PAD Combination by AHCT in MM

NCT01370434

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Asan Medical Center Seoul, Asanbyeongwon-gil, Songpa-gu, South Korea

View Trial Details

Completed

Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX

NCT00749476

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +7 more
Locations: Dr. Lambert Le Kremlin-Bicêtre, France

Pr Chambost Marseille, France

Dr. Hassoun Montmorency, France

Pr Schved Montpellier, France

View Trial Details

Completed

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery

NCT00243659

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Cardiovascular Diseases, +9 more
Locations: La Jolla, California, United States

Detroit, Michigan, United States

Detroit, Michigan, United States

Chapel Hill, North Carolina, United States

View all 17 locations

View Trial Details

Completed

The Effect of Epoetin Alfa on the Anemia of Patients With Multiple Myeloma

NCT00270101

Conditions: Anemia, Blood Protein Disorders, Cardiovascular Diseases, +13 more
Locations: Not specified

View Trial Details

Completed

The Effect of Epoetin Alfa on the Anemia of Patients With Selected Cancers Receiving Chemotherapy

NCT00270166

Conditions: Adnexal Diseases, Anemia, Blood Protein Disorders, +59 more
Locations: Not specified

View Trial Details